Biomechanical Effects of Duloxetine on Bladder and Sphincter Muscle Function in Women in Pure Genuine Stress Incontinence
Completed · Phase 2 · Has a placebo group
Conditions studied: Urinary Stress Incontinence
In brief
Double-blind placebo-controlled study of the biomechanical effects of duloxetine compared with placebo in the treatment of women with pure genuine stress incontinence
Key facts
- Study ID
- NCT00190567
- Run by
- Eli Lilly and Company
- People needed
- 50
- Starts
- 2001-10-01
- Expected to finish
- 2006-04-01
- Last updated by the study team
- 2007-01-26
Who can join
Age: 18 and older, up to 75. Sex: female. Healthy volunteers: not accepted.
You may qualify if…
- Female
- Between 18 and 75 years of age
- Diagnosis of GSI
- Have discrete episodes of incontinence
You may not qualify if…
- Positive urine culture at visit 1
- Use of MAOI
- Have had continence or urethral surgery
- Use of anti-incontinence device, vaginal pessaries or medications for the treatment of urinary incontinence
- Began pelvic floor muscle exercises within 6 months prior to study entry.
Where it is running
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Monday - Friday from 9:00 AM to 5:00 PM Eastern Time (UTC/GMT - 5hours, EST), or speak with your personal physician — Indianapolis, Indiana, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.